Skip to main content
OpenTrials
Completed

NCT Number: NCT01958424

In Vitro Fertilization Outcomes in Metabolic Syndrome

The purpose of this study is to examine the effect of metabolic syndrome in over-weight women on IVF treatment outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Sapir Medical Center, Meir Hospital

Kfar Saba, Israel

About this study

This porpuse of the study is to examine the physiology of CRP during the IVF cycle in and to evaluated the effect of CRP in patient with and without metabolic syndrome on IVF outcomes

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women undergoing ivf treatment

Exclusion criteria

  • inflammatory disease
  • acute conditions

Treatment and study plan

Primary outcomes

  1. success or failure of ivf treatment

    Time frame: within 1 year from intiation of ivf treatment

    success or failure of a treatment will be determined by beta-Human chorionic gonadotropin test, number of oocyte retrieved or fertilized and embryos quality.

Secondary outcomes

  1. blood levels of C-reactive protein

    Time frame: within 1 year from initiation of ivf treatment

  2. follicle liquid levels of C-reactive protein

    Time frame: within 1 year from initiation of ivf treatment

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Official study title

The Influence of Metabolic Syndrome on in Vitro Fertilization Treatment Outcome

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Oct 9, 2013
Registry last updated
May 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.